Technology
Moderna and Merck report positive skin cancer vaccine trial
Moderna and Merck have announced positive Phase 3 trial results for intismeran autogene, an experimental mRNA skin cancer therapy tested with Keytruda.
Moderna and Merck have announced positive Phase 3 trial results for intismeran autogene, an experimental mRNA skin cancer therapy tested with Keytruda.